Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Overview of attention for article published in New England Journal of Medicine, September 2018
Altmetric Attention Score: 196
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (64th percentile)
Mentioned by
- news
- 14 news outlets
- blogs
- 2 blogs
- policy
- 1 policy source
- 106 X users
- patent
- 11 patents
- 3 Facebook pages
- googleplus
- 1 Google+ user
- 3 Redditors
- guideline
- 5 clinical guideline sources
Readers on
- mendeley
- 325 Mendeley